Investors Taking Note Of Cowen's GenMark Diagnostics Upgrade

By: via Benzinga
GenMark Diagnostics, Inc (NASDAQ: GNMK) shares are trading higher by $1.45 (18 percent) at $10.27 in Friday's session. Investors ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.